Acelyrin News

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Maintains Target Price $6

Moomoo NewsAug 20 08:33 ET

ACELYRIN Price Target Cut to $6.00/Share From $13.00 by Morgan Stanley

Dow JonesAug 19 13:09 ET

Acelyrin Analyst Ratings

BenzingaAug 19 13:01 ET

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Cuts Target Price to $6

Moomoo NewsAug 19 09:31 ET

ACELYRIN, INC.: Hold Rating Maintained Amid Strategic Pipeline Shift and Extended Cash Runway

TipRanksAug 19 08:47 ET

A Quick Look at Today's Ratings for Acelyrin(SLRN.US), With a Forecast Between $6 to $20

Moomoo NewsAug 15 09:01 ET

Acelyrin Analyst Ratings

BenzingaAug 14 12:08 ET

A Quick Look at Today's Ratings for Acelyrin(SLRN.US), With a Forecast Between $6 to $20

Moomoo NewsAug 14 09:00 ET

Piper Sandler Keeps Their Buy Rating on ACELYRIN, INC. (SLRN)

TipRanksAug 14 07:16 ET

ACELYRIN, INC. Maintains Hold Rating Amidst Mixed Clinical Results and Competitive Market Challenges

TipRanksAug 14 06:37 ET

Buy Rating Affirmed: Strategic Focus and Promising Pipeline of ACELYRIN, INC.

TipRanksAug 13 22:21 ET

Acelyrin Analyst Ratings

BenzingaJul 8 09:40 ET

Analysts Offer Insights on Healthcare Companies: ACELYRIN, INC. (SLRN), Arrowhead Pharmaceuticals (ARWR) and NovoCure (NVCR)

TipRanksMay 24 06:55 ET

Analysts Offer Insights on Healthcare Companies: Poseida Therapeutics (PSTX), Greenwich LifeSciences (GLSI) and ACELYRIN, INC. (SLRN)

TipRanksMay 22 06:25 ET

Acelyrin Analyst Ratings

BenzingaMay 22 06:12 ET

Acelyrin Analyst Ratings

BenzingaMay 15 11:47 ET

Buy Rating Affirmed for ACELYRIN, INC. on Solid Financials and Promising Pipeline

TipRanksMay 15 06:25 ET

Acelyrin Analyst Ratings

BenzingaMay 9 13:57 ET

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), ACELYRIN, INC. (SLRN) and Moderna (MRNA)

TipRanksMay 9 12:30 ET

Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and ACELYRIN, INC. (SLRN)

TipRanksMay 9 12:30 ET